Clinical Trial

Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment

Study acronym: EASOFDIMBCT
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study analyzes the use of DS8201 in the treatment of metastatic breast cancer in the real world by analysis, exploring whether there are differences in effectiveness and safety between real-world conditions and clinical trials.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-31; most recent amendment 2025-07-07.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-07-07
Trial Details
NCT Number NCT06914661
Lead Sponsor The First Hospital of Jilin University
Conditions Breast Cancer Metastatic, Efficacy and Safety
Enrollment 200 participants
Start Date 2025-05-25
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-08